The Beatrice Hunter Cancer Research Institute logo
  • Dr. David Michael Conrad, BSc, MD, PhD, FRCPC (Hematological Pathology)


Hematopathologist, QEII Health Sciences Centre; Medical Director, Microscopy Laboratory, NSHA Central Zone; Consultant Hematopathologist, IWK Health Centre; Associate Professor, Departments of Pathology and Microbiology & Immunology, Dalhousie University


QEII Health Sciences Centre, IWK Health Centre, Dalhousie University

Research Interests:

Cancer detection, point-of-care, assay optimization, anti-cancer peptides

How to improve cancer diagnostics

By collaborating with several wonderful researchers at Dalhousie, I work on the development and optimization of methods to detect blood cancers. I am helping Dr. Alan Fine develop and clinically validate a novel point-of-care device to rapidly detect blood cancers. Dr. Fine’s device requires no more than a pinprick blood volume, and generates results in a matter of minutes. Dr. Robert Liwski and I have undertaken a retrospective study to determine the power of hospital laboratory automated blood analyzer data to identify the patient samples that are most likely to contain acute leukemia.

What brought you to your current institution? 
I received undergraduate, graduate, and medical degrees from Dalhousie prior to completing my residency in hematological pathology. I joined the medical staff in NSHA Central Zone as a hematological pathologist and was appointed Assistant Professor at Dalhousie University in 2015 and promoted to Associate Professor in 2021.

Hometown: Timberlea, NS

Learn More about my research:

Involvement with BHCRI to date:

Dr. David Conrad is an Associate Member

Site by: Spectacle Group